Healthcare >> CEO Interviews >> March 8, 1999

Joshua D. Schein – Siga Pharmaceuticals Inc (sgph)

JOSHUA D. SCHEIN, Ph.D. is a founder of SIGA and has served as its Chief Executive Officer since April 1998. Previously, Dr. Schein served as Vice President Investment Banking at Josephthal Lyon & Ross, an investment banking and brokerage firm. Dr. Schein is also a founder of Virologix Corporation and Callisto Pharmaceuticals, two private biotechnology companies, and is a founder of DepoMed, Inc., a public drug delivery company. Dr. Schein received a Ph.D. in Neuroscience from the Albert Einstein College of Medicine and an M.B.A. from the Columbia Graduate School of Business. Profile
TWST: Could you start out by giving us an overview of SIGA

Pharmaceuticals, your history and your activities, please?

Mr. Schein: SIGA was formed in 1995, based on technologies that